Coeptis Therapeutics, Inc. Operating Loss Carryforwards
Coeptis Therapeutics, Inc. had Operating Loss Carryforwards of $23.00 million as of 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2022-03-11
- 2021-12-31: Operating Loss Carryforwards $23.00M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2021-12-31 | $23.00M 10-K · filed 2022-03-11 |